CLINICAL_TRIALS
trial_result
· 2022-06-28
Clinical Trial Update: SHIELD II Clinical Investigation [NA]
Summary
Clinical trial SHIELD II has been terminated; results posted in 2022. No specific safety or efficacy conclusions are provided in the summary.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Abbott Medical Devices | Conditions: Coronary Artery Disease | NA | Status: TERMINATED | Results posted: 2022-06-28